[BidClub_]
Yet Another Value Podcast · · 28 分钟

2026年7月随想杂谈

Andrew Walker

YouTube
TL;DR
  • Walker 的核心框架是:主动投资是“一场傲慢的游戏”,最难的能力在于判断这种傲慢何时已经不再有依据。 买入一只股票的基准回报率大致就是市场回报,因此每次买入都等于宣称自己知道市场不知道的事情,在一个技术上零和的游戏里——“你拿走的每一分超额收益,都必须来自某个地方”。反复出现的问题是,什么时候该承认“不是市场的问题,是我的问题”,无论对象是一只个股,还是他举的那类持有15–20年、年化回报8%而标普达到10%的基金。
  • 他给个股仓位提供了一个具体经验法则:3年规则。 如果一只股票买入3年后仍然原地踏步,“答案大概就是你自己”——他勾勒出典型的亏损路径:以15倍市盈率买入“一家非常优秀的公司”,随后每年退化,最终变成“一个重组标的”,估值也从15倍压到10倍,再到6倍。
  • 他最坦率的自我批评是:2025年末他已经看到 AI 正在发生拐点——“这真的开始改变我的工作流了”——却没有做出交易,部分原因是“我是价值投资者。我是事件驱动投资者”。 他现在反问,那究竟是纪律,还是“心理障碍”;他还提到 SanDisk 在2025年3月/4月分拆上市时,估值“只有明年盈利的0.5倍左右”,后来却成了“一只彻头彻尾的大牛股”。
  • 一个具备交易意义的结构性判断是:Nvidia 已占标普500指数的7.5%,以该指数为基准的主动管理人如果不持有 Nvidia,“从技术上说就是做空 Nvidia”——把 AI 敞口合并计算后,实际上是在做空指数中一大块权重。 反面同样成立,这也解释了为什么价值投资者在2000–2004年前后跑赢幅度最大:互联网公司泡沫破裂时,它们已经成为指数中的大权重,而价值投资者完全没有持仓。
  • 他过早卖出的账本相当惨烈:持有现金净额为正的生物科技公司 uniQure 时,公司公布了出人意料的 Huntington's 结果,股价从约5–6美元涨至约60美元的高点;他说自己是在低于现金净额时买入、接近现金价值时卖出,如今股价约40美元。 15个月前,他以18–19的价格附近买入前 Yandex 公司 Nebius,并在20多的高位卖出;如今股价已到230。那个他始终无法解决的问题是:“你是不是换仓太快了……还是变得不耐烦,没有让这些投资逻辑充分展开?”诚实的反面事实是,他许多生物科技投资的胜负,都取决于即将到来的II期和III期试验能否“正面而不是反面”。
  • 在伦敦——他口中的“我最喜欢的一个小型新兴市场”——Mitie(MTO)刚刚成为他认为今年第11笔、规模超过10亿英镑的 FTSE 250 收购交易,市场标题甚至警告“我们会把上市公司买光”。 私募股权正在支付很高的溢价(他认为 EasyJet 已被 Apollo 收购),这说明私人市场估值可能远高于公开市场估值;但11笔交易只占 FTSE 250 的4–5%,因此一位集中投资的管理人很可能一笔也没持有,而 Walker 自己的3–4个伦敦仓位则“一动不动”。
  • 伦敦这个陷阱凝结了他的更大主题:“每个投资者都希望投资于低效市场,直到自己真的投身于一个低效市场。” 许多公司内部人持股很低,管理层又可能因为担心失去养老金、薪资和董事会津贴而不愿出售,于是被收购这一催化剂变成了抛硬币式的赌局——剩下的选择,要么做激进主义投资者,要么离开这个市场,要么重新调整自己的价值投资原则。
摘要 · 为研究而整理的核心内容

1. 买入股票是一种傲慢行为——真正的能力在于知道何时收回这种傲慢

  • Walker 的框架是:买入股票时,基准回报大致就是市场回报,而投资在技术上是零和博弈——“不可能所有人都创造超额收益。你拿走的每一分超额收益,都必须来自某个地方。”每次买入都在宣称:“我比市场共识更聪明。我知道市场不知道的事情。”这种优势可能来自对基本面的彻底掌握,也可能来自识别出一个正被追加保证金、被迫卖出的卖家。
  • 这个镜像问题有两个层次:一是单个仓位——“如果它原来是10,后来跌到8,什么时候只是市场正常波动,什么时候是市场在告诉你某些事情?”二是他看到的那些泛化的长期基金案例——比如管理人运营15–20年,年化回报8%,而标普达到10%。管理人究竟什么时候必须承认:“当初推出这只基金,是我太傲慢了?”
  • 他为坚持提供的部分辩护是:“我今天比昨天更会投资,不只是比昨天,尤其是比2年前、5年前……也许接下来的10年会不一样。”他明确表示自己不知道答案——“我不知道答案”是真实的保留,而不是修辞。

2. 3年规则与价值陷阱的解剖

  • Walker 的经验法则是:“如果你投资一家公司,3年过去了,股票基本原地踏步,那就该认真照照镜子了……答案大概就是你自己。”
  • 他画出的亏损路径,值得保留其原有精神:以“15倍市盈率左右买入一家非常优秀的公司”,一年后变成“它可能没我想的那么好,但现在只有10倍市盈率”;接着又变成“还算可以的一家公司,但只有6倍市盈率,而且他们还在回购股票”;最后则是“这是一项重组交易”——投资逻辑随着估值层层下跌,被悄悄改写。

3. 演进还是投降:错过 AI 交易与 Fundsmith 的问题

  • 他的自我问责是:去年年底,他“很清楚地看到 AI 正在发生拐点并加速”,还写文章说 AI 正在改变自己的工作流,但“没有做任何 AI 交易”——一部分原因是“超出了我的能力圈”,另一部分是“我是价值投资者。我是事件驱动投资者,但我看不到这里的价值,也看不到这里的事件”。随后,AI 相关股票“走出了一轮世代级行情”。
  • 他认为,这些机会在价值层面其实清晰可见:2022年末的 Meta “便宜到了世代级别”;2015–2016年的 Netflix “便宜得离谱”,正值 John Malone 说它已经“突破逃逸速度”之际;SanDisk 在2025年3月/4月分拆上市时,“只有明年盈利的0.5倍左右”。他讲过的最佳轶事是:Micron 内部曾讨论,是否应该向 Apple 要求未来3年供应合约涨价100%,并预计 Apple 会谈到50%;结果“Apple 直接在合同上签了字,一次性接受。这非常不像 Apple”。
  • 他把这一经历与那些在1999年末或2000年初放弃价值原则、随后被互联网股票打得鼻青脸肿的价值投资者作对比。他提到 Fundsmith 的一封信,信中说他们坚持“硬核价值投资原则”期间一直跑输,并将“开始对市场作出反应”——转向动量和算法。那封信“在很多地方都被骂得很惨……如果让我给出先验判断,我可能会说他们被骂得有道理”——但他无法回避这个问题:“究竟什么时候是价值投资原则拖累了他们,什么时候又只是他们把原则抛到一边、去追逐动量?”
  • 他反对建模的立场也有一个例外:他避免做大量模型,因为“你很容易只见树木、不见森林”;模型可以显示公司拥有20倍现金,或自由现金流收益率达到20%,但业务可能正在崩塌,现金也正在消失。不过他承认:“如果我当时多做一点建模,也许我会说,等等,我看到一个拐点。”

4. 如果你的基准是标普、却不持有 Nvidia,你就是在做空 Nvidia

  • 机制很简单:Nvidia 占标普500的7.5%,而且“无论你作为主动投资者喜不喜欢,你大概都要以标普500为基准”——因此不持有就“从技术上说是在做空 Nvidia……Nvidia 上涨,而你一开始就落后于人”。如果 Nvidia 下跌,不持有则会带来帮助。
  • 历史上的反例证明了镜像关系:价值投资者在2000–2004年前后的跑赢幅度最大,因为互联网公司已经成为指数中的大权重,而他们一个都没持有——指数下跌20%,部分价值投资者却上涨20%。他尚未解决的问题是:“我不持有这些敞口时,是否真的有意在,引用一句话,主动做空它们?”

5. 过早卖出的复盘:uniQure、Nebius 与反事实难题

  • 回看2025年4月前后的那套充满“绝对大牛股”的组合:当时 uniQure 是一家股价远低于现金的生物科技公司,公布了出人意料的结果,显示其药物可能成功治疗 Huntington's disease。股价从约5–6美元涨到约60美元的高点,Walker 讲话时约为40美元;他说自己是在低于现金净额时买入、在“接近现金价值”时卖出——“表现还行,但真希望我拿住了。”
  • Nebius 的完整故事是:它曾是前 Yandex,即“俄罗斯的 Google”,遭到制裁,被 Nasdaq 摘牌,冻结了18个月,之后进行了一次重大重启。“这对 Andrew 来说算是挺有意思的。”他的成本大约在18–19,15个月前在20多的高位卖掉最后一批仓位;“今天股价是230。”更聪明的朋友认为其分部加总价值高得多,此外还有“新云业务带来的免费上行期权”——“我觉得事实证明他们可能是对的。”
  • 他真正的不确定性包括两面:“你是不是换仓太快了……或者反过来——本来属于你的那部分收益、那个你当初来投资的情形,已经基本兑现了?”许多生物科技投资的结果,都依赖II期和III期试验能否“正面而不是反面”,而且“也许我还不够重视反事实分析”。
  • 他还质疑比较对象的选择:Nevro 拥有大量现金,但也可能转型成 AI 标的;在 AI 成功的世界里,这种转型尤其有效。现金净额为正的持仓可能在大多数情景下都能表现不错,而与 AI 挂钩的标的,可能主要只在当前这一种情景下有效。

6. 伦敦:一个似乎唯一退出方式就是被收购的新兴市场

  • 本周的数据点是:Mitie(MTO)以很高溢价被收购——“这是今年以来 FTSE 250 第11笔规模超过10亿英镑的收购”——市场标题是“我们会把伦敦上市公司买光”。他认为 EasyJet 也被 Apollo 以很高溢价收购。这些交易说明,私人市场价值可能远高于公开市场价值。
  • 供需难题在于:供给收缩本应推高剩余公司的估值倍数——他的类比是澳大利亚因养老金资金被迫进入有限股票池而形成的结构性溢价——但“剩下的公司似乎并没有获得多少提振”。
  • 实际陷阱是:11笔收购只占 FTSE 250 的4–5%,因此一个持有10只股票的集中型管理人很可能一笔也没持有;Walker 持有3–4只伦敦股票,其中一只“因为失望而卖掉了”,并说自己的股票“一动不动,一动不动,还是一动不动”。许多公司内部人持股很低,而管理层可能不愿出售,因为出售会让他们失去养老金、薪资和董事会津贴。于是,被收购的催化剂就成了抛硬币。
  • 他的选择是做激进主义投资、转去另一个市场,或者调整自己的价值投资原则。他最后说:“每个投资者都希望投资于低效市场,直到自己真的投身于一个低效市场。”老玩家的回应则是:“欢迎加入,朋友。”
完整逐字稿
Andrew Walker

All right, hello and welcome to yet another value podcast. I'm your host Andrew Walker. Today is my monthly random ramblings for the month of July 2026. I say today, but it's actually yesterday and then of course because I am not a professional podcaster, I botched the intro so I'm re-recording it today. But I think I've got a fun one. It's just, you know, as I do in every random rambling, I'll remind you nothing on this podcast is investing advice. See the disclaimer at the end of the podcast. See the disclaimer in the show notes. But you know, this is just me rambling for 20 25 minutes. It's I think it's specifically 23 minutes and 36 seconds cuz I recorded yesterday. About things that have been on my mind for this month. So to start, we're going to go with the confidence of being an investor. You know, being an active investor and if you're listening to this podcast, you probably are an active investor in some way, shape, or form. You know, it is a game of arrogance. Every time you buy a stock, every time you do research, you are saying I think I am so smart. I think I understand something so much different than the market that I think I can beat the market and generate alpha, right? That's ultimately I mean investing is fun, it's interesting, but ultimately the reason you're doing it is generate alpha and beat the market in some way, shape, or form. So and that is a very arrogant act. So I'm going to talk about that and then specifically like, you know, when is the arrogance deserved and when do you need to kind of I talk about looking yourself in the mirror all the time and say, “Hey, I I am wrong.” And that could be I am wrong on this stock that I've done a lot of work on and thought I had a differentiated view. When do you need to say, “It's not the market, it's me.” And then, you know, you can start looking at it as or if you're underperforming the market, when do you look at the mirror and say, “Hey, it's not the market, it's me.” You know, is it after a day? No, probably not after a day. Is it after 50 years of underperformance? Yeah, it's probably before 50 years. So there's some place in between and you know, there's all these stories of value investors throwing in the towel at the end of 1999 after underperforming for a few years in dot-com bubble and if they had just held on a little bit longer. Is that a pot of gold at the end of the rainbow? Is that delusion? So I'm going to talk about that. Very much related, talking about evolution as investor. how do you continue to evolve but while kind of sticking to your principles. Then we're going to go to just a little bit of, you know, as again as an active investor, if you sell a stock and then the stock does really well, how how do you measure that? How do you think about that? Did, you know, sometimes companies hit lottery tickets. Did you sell a company and they just kind of struck good lightning and hit a lottery ticket? Or do you need to look and say, “Hey, I might I might be getting bored and selling before my thesis fully played out?” And as I try to do always, I use myself as an example for that. Finally, wrap it up by talking about the London Stock Exchange, which I have made lots of jokes about. It is an emerging market, but things are getting taken out for huge premiums over there and just some quick thoughts on my favorite little emerging market and the frustration of investing in the market where kind of the only way to get out is getting taken out at a big premium. Nice if you're in the companies that get taken out at a big premium, kind of frustrating if you don't. So, we'll go there. We'll hop to all that in 1 second, but first, a word from our sponsors. Today's podcast is sponsored by fiscal.ai. Fiscal.ai is a modern financial data provider for global equities. In addition to their web-based terminal, Fiscal is one of the leading data connectors for Claude and ChatGPT. With their self-serve API, you can connect in real-time fundamental data directly to your LLM. And look, I said it in podcast before and I'll say it again. They're not just an advertiser. I've been doing lots of cool stuff with Claude and co-workers in particular, building all sorts of awesome tools and I needed API. So, guess what? I signed up with my own money, tossed my own credit card down and today, fiscal.ai, I need you guys to plug into my Claude co-worker for me so I can keep building these cool tools and have access to real-time fundamental data and stock prices to everything. And that includes more than 20 years of financial statements, ratios, filing segments, KPIs, and all sorts of other things. Unlike other providers, their data updates within minutes of earnings reports, not days. So, whether you want powerful out-of-the-box terminal or the real-time AI connector with API, you can use my link at fiscal.ai/yav, that's fiscal.ai/yav, to get 15% off. And they'll be in the show notes, too. All right, let's dive into the topics. Mhm. Okay, first off big I want to talk about something that's been on my mind a lot about it. I have some friends who I talked to who have probably heard me ranting or thinking on this a few times. So, if they're listening to the podcast, they're they're probably hearing duplicate or deja vu, but you know, being an investor is an interesting game of confidence, betting on yourself, and kind of arrogance. What do I mean by that? The base rate when anyone buys a stock is that it’s going to perform in line with the market, right? Investing is technically a zero-sum game: everyone who buys or sells—one side’s right, one side’s wrong. You can’t have everyone generate alpha. Any alpha that you take has to be taken from somewhere, right?

So, for you to generate alpha, someone else has to generate a little bit less. If you buy a stock, you’re saying, “I am smarter than the wisdom of the markets. I know something the market doesn’t.” What you know can be very different, right? You might know the fundamentals of the business cold and know that the market’s missing that. You might know there’s a forced seller on the other side, and the reason the stock is puking is because there’s a forced seller getting margin-called, or whatever it is.

It’s a game in arrogance. It’s a game in beating the base rates, right? Because the base rate when you buy a stock is that it kind of generates the market return. So, it is a game in arrogance, and there are 2 places where I think that is interesting.

One, most of the people who listen to this podcast—Random Ramblings is a unique episode where it’s just me rambling for 30 minutes, but most of the time you listen to this podcast, it’s an hour-long deep dive into a company or stock idea. It’s not investing advice, because nothing is, but it is an hour-long deep dive into a company, hopefully getting you up to speed on the fundamentals, up to speed on the opportunity, and up to speed on why the guest, who is generally a professional investor, thinks that this company, as I like to ask, presents a risk-adjusted alpha opportunity.

If you’re listening to that, it’s because you’re looking for what you’re trying to beat the market. You’re trying to find alpha. When do you, as an arrogant person who thinks they can beat the base rate, say, “Hey, enough is enough?” Is it—and I’ll talk about that in the individual stock point in a second.

It can be an individual stock, right? I’ve mentioned, and I’ll come back to this later, that I’ve increasingly come to the 3-year rule. If you invest in a company and it’s been 3 years and the stock has kind of gone nowhere, it’s time to really look in the mirror and say, “Hey, is it me or is it the market?” I hate to say it, but if it’s been 3 years, the answer’s probably you. We’ll talk about why that fails in a second.

A lot of the big losses I’ve had as an investor have been in a company where I buy it and say, “Hey, this is a really good company. I’m buying it at, like, 15 times earnings.” Then, a year later, I say, “Hey, it probably wasn’t as good as I thought, but now it’s at 10 times earnings, so the price is better.” Then, a year later: “Hey, I don’t even think this is a good company. It’s an okay company, but it’s 6 times earnings and they’re buying back stock, so boy, look at that free cash flow yield.”

Then, a year later, I say, “Hey, this is a restructuring play.” You started out with a great company, but it became a restructuring play. I’m going off topic, but whether you’re looking at the individual company and you’re saying, “The arrogance to buy the individual company,” when do you say, “Hey, I was wrong?”

It’s hard because, yes, we as investors and thinkers want to have open minds and all that sort of stuff, but you were arrogant. You had a belief. You saw something the market was missing. When is the market, if the stock was at 10 and it goes to 8, just giving you the dips of the market, versus saying, “Hey, the market is telling you something,” or, “What you saw wasn’t there?” Very difficult.

The other reason I mention this is that I get a lot of investor letters. I’ll see some investor letters, and the person will say, “Hey, the fund has been running for 15 or 20 years, and the S&P is up 10% annualized over those 20 years, and we’re up 8% annualized. We’re up 2% annualized. We’re down 10% annualized.” Whatever it is.

When do you, as an investor, look and say, “Hey, I’m doing something wrong? I was arrogant to launch this, and I shouldn’t be doing this, or I need to look in the mirror and reassess the process?”

It’s interesting. Again, 20 years is telling you something, but you launched arrogantly, and maybe you say, “I mean, I believe this about myself, right? I’m always learning. I’m a better—I’ve said it so many times on the podcast.

I'm a better investor today than I was not just yesterday, but particularly 2 years ago and 5 years ago. I'll go read some of the stuff I wrote 5 years ago and be like, "What was this guy thinking?" Hopefully, I'm continuing to get better. So even if you launched and said, "Hey, arrogantly, I think I can beat the market," maybe you didn't beat the market over the past 10 years, but you still got that arrogance treatment. You're a much better investor now. Maybe the next 10 years are different. I don't know the answer.

There are 2 places I would want to pull on that I think are related. Number 1, if you're investing—whether you're doing it professionally or even in your PA—you're doing it because hopefully you enjoy the process, but you want to beat the market, right? My question is, if you underperform, when is it time to look in the mirror and say, "This process needs to evolve"?

I was thinking about this because you'll see so many letters. I try not to call anyone out; I never call anyone out. I try to bring this back to me, so I'll use myself. I think about late last year, when I saw pretty clearly that AI was inflecting and accelerating. You can look at the blog—I was talking about it and saying, "Hey, this is really starting to change my workflows." I saw that and didn't pull the trigger on any AI trades.

I think part of that was me saying, "This is outside my wheelhouse," and part of that was me saying, "Hey, I'm a value guy. I'm an event guy, and I don't see the value. I don't see the events here." A lot of the AI stocks went on a generational run on the heels of that. I'm using myself, not someone else, but I do think we can broaden this out to someone else.

You'll see these letters where people will write, year after year, "The markets are up. The S&P was up 15% this year, and we're up 10%, but we're sticking to our value investing principles." When is it time to look and say, "Hey, are these principles that we've been investing on serving us? Do we need to change them? Do we need to throw them out the window entirely?"

By the way, how many times have you heard of the value investor who stuck to their principles and threw them out the window in late 1999 or early 2000, only to get their face ripped off on internet stocks? I try not to call people out, but I think a lot of people have been referencing the Fundsmith letter. I'm sorry, Chris. The letter said, "Hey, we've been underperforming for the past few years because we've been sticking to our hardcore value investing principles, and we're going to start being responsive to the market. The market cares about momentum, algorithms, whatever it is. We're going to start incorporating that."

They got dumped on in a lot of places, and if I'm giving my priors, I would probably say rightly so. But I think it's interesting. These are people trying to evolve, and they're saying, "Hey, this is how the game is played today, and we're going to start trying to play that game." When were the value investing principles holding them back, versus when were they just throwing their principles out the window to chase momentum? I think it's a really interesting question.

Some of the stuff they talked about was a little bit of chasing near-term performance, but I do think that if you're reading one of these letters and it's a fund that's been calling everything overvalued for the past 12 years, buying legacy businesses, and nothing's working, at what point is it time to look at yourself and say, "Hey, Meta in late 2022 was generationally cheap"?

I'll tell you that Netflix in 2015 and 2016 was crazy cheap. A lot of us remember that. That's around the time I think John Malone said Netflix had gone past escape velocity. They had gone off the charts, and nobody was catching them. You could have looked at that, and you would have done great if you had bought Netflix, particularly if you had shorted legacy media companies against it.

Everybody likes to say, "Hey, Micron or SanDisk—when SanDisk spun out in March or April of 2025, it spun out at 0.5 times next year's earnings because it's going to earn so much this year. That's really fucking cheap." No one knew they were going to earn that at the time, but the stock has been an absolute screamer.

It is worth asking, "Hey, bringing it back to myself and missing these AI trades, is it because I need to look at myself in the mirror and say, 'Yeah, they might not have fit into my wheelhouse, but these things were very cheap and the numbers were inflecting'?" Did you have a mental block, Andrew? Did you have a mental block that prevented you from looking at these things because they didn't fit your neat and tidy bow of, "Hey, this is a spin-off trading at 4 times cash flow—buy, buy, buy"?

If you had done the work, you could have seen the inflection. I tell people I don't like to build extensive models because I think people can get so caught up in the model and so caught up in focusing on the model that they kind of miss the forest for the trees, and it looks great on the model and the business is falling apart and you're like, “I'm buying it at 20 times cash, a 20% free cash flow.” It's like, “Yeah, but the cash was all gone because the business is falling apart every which way.” But, you know, if maybe if I had done a little bit of modeling work, I could have said, “Hey, I'm seeing an inflection.” Maybe I could have talked to some customers who were saying, "Unbelievable, man, we can't get filled." There was the story of Apple just going to Micron, and Micron was having a meeting where they were debating internally, "Hey, we say a 100% price increase for 3 years of supply, and then they'll negotiate it down to 50%." They went and said, "100% price increase for the next 3 years," and Apple just signed on the dotted line instantly. That's very un-Apple-like.

Maybe you could have seen that story, seen the inflection, and seen the model. Breaking through and evolving your process raises the question: when is my fixation on cash flow holding me back from seeing the opportunity? If I'm evolving from that fixation, is that me chasing momentum, chasing the thing that's worked in the recent past, or is that me evolving and improving?

I don't know, but it's my random rambling, so I get to throw out everything that I'm thinking about to you, and we can talk about it. You can reach out to me, and we can have a discussion.

Oh, and just briefly on this, I was having this discussion with a friend while we were grabbing coffee. Nvidia is 7.5% of the S&P 500. Whether you like it or not, as an active investor, you're probably getting benchmarked against the S&P 500.

Even if you say, "I can't tell you how many times I've said, 'I don't own anything in the S&P 500,'" you always kind of get benchmarked to the S&P 500. Nvidia is 7.5% of the S&P 500, so if you don't own Nvidia and you're getting benchmarked to the S&P 500, you're technically short Nvidia. That's kind of how it works. Nvidia goes up, and you're starting from behind the 8-ball. Nvidia goes down, and it's beneficial.

That's why a lot of value investors who invest in low-cash-flow businesses had their peak outperformance around 2000 to 2004. All the internet companies had grown so big and were such big parts of the indexes. As all of those companies fell apart, none of the value investors owned them. They owned great cash-flowing businesses that actually went up. The indexes were down 20%, and all these guys were up 20%. Boom, that's clear.

It's worth thinking about: if you're an active investor, by not having any AI exposure, you can say, "I don't invest in that stuff. I am the value guy. I don't invest in any of that stuff." Well, 2 things: that means you're short them, for 1, and, 2, coming back to it, should we have our minds open to that?

I used Nvidia, but if you start adding all the AI and everything, it's a big piece of the index. If you're saying, "I'm not going to invest in that," I wish I had it for the past 6 months, but you're actually short a huge piece of the index. How do you start thinking about that? You can say, "Hey, I might be benchmarking against an index, but I invest in different stuff." That's all true, but you are short that, and you kind of have to come to grips with it.

It's something I've been thinking about: do I mean to be, quote-unquote, actively short these by not having this exposure? I think it's a very interesting thought.

Let me turn to something related. I was doing some work and I saw—again, I like to bring everything back to myself, so you know that I'm talking about things that I'm thinking about. Honestly, with very rare exceptions, I try not to dunk on anyone on this podcast. Every now and then, somebody will be like, "Hey, you said that."

“Did you mean that about me?” I’ll be like, “Bro, in a Don Draper way, I don’t think about you at all.” I’m not trying to dunk on anyone, with very few exceptions. I was looking at a portfolio of mine and doing some work, and the portfolio had some—oh God, it’s hard to say—absolute bangers in it, right?

The portfolio was from around April 2025. As you’ve been following the blog, you know I got really invested in net-cash biotechs then. I had a pretty quick trigger as they traded up, and a lot of the bangers were net-cash biotechs that had a lot of success in Phase 3. For instance—and this was actually a little before April 2025—I used to have a huge position in uniQure, because for a while uniQure was one of the only biotechs trading well below cash value, and they also had some other assets in there.

uniQure, for those who don’t know, posted surprising results that suggested their drug might have a lot of success curing Huntington’s disease. When they announced that, the stock went from $5 or $6, whatever, to a peak of around $60. There was some drama, but right now it’s trading at $40. I was looking at that and I said, “Hey, I had this big position in uniQure, and I sold it for—no, I did okay. I bought it for under net cash and kind of sold it around cash. I did okay. I wish I had held it,” right?

Several stocks were like that, and then there were some other stocks that have done really well. To be blunt, they’ve done better than my portfolio. I’ll name one: Nebius. Nebius was the former Yandex. Yandex is like the Russian Google. They got sanctioned, they delisted from the Nasdaq, and the stock was frozen for 18 months. Then they did this huge reboot and all this sort of stuff, and I was like, “Oh, this is kind of neat for Andrew, right?”

I bought the stock. I think my cost basis was around $18 or $19, and I probably sold the last of the stock in the high $20s. Great trade, right? Nope. I sold it 15 months ago, and the stock is at 230 today, right? So, again, I’m not breaking new ground when I say, “Guess what? My portfolio has not kept up with a 30-to-230 move in 15 months,” right?

A few like that. I look at that and I say, “Okay, a lot of this stuff I sold—and I had pretty good positions in these—has done better than what my portfolio is.” I need to look at myself, and I’m struggling with it, right? Did I sell because I mentioned Nebius? The forced selling happened. I was buying because I was like, “Hey, I’m buying kind of at cash.”

I know a lot of very smart people who thought the sum of the parts was much higher. Nebius, for those who don’t know—I’m not going to go through it—the real reason they’ve gone up is that they’ve pivoted into a neocloud model. But they had some investments in kind of interesting, growthy plays, and some people smarter than me, obviously, were saying, “Hey, the way I was valuing them was much lower than the way they were valuing them, and I think they’ve been kind of proven right.”

They would have said, “Hey, Andrew, you’re selling at $30. You’re still way below the sum of the parts, and forget all the free upside optionality of the neocloud.” I’m kind of looking at it and saying, “The net-cash drugs—I bought a lot of these for 60% of cash and sold them at 100% to 110% of cash, or maybe 90% of cash—and a lot of them have worked because Phase 2 and Phase 3 trials came up heads instead of tails, right? They were successful instead of failing.”

So, I’m just struggling. I’m looking at it and saying, “Hey, Andrew, are you churning through the portfolio too fast? Are you getting impatient and not letting these theses play out? Or, conversely, are you kind of like—there is something to, ‘Hey, the money that is yours to be made, the situation you were here to invest in, has kind of played out,’ and maybe I’m not counterfactually hard enough, right?”

There are certainly stocks I’ve sold that are down, but maybe I’m not counterfactually hard enough. Either trial could have been a failure, all this sort of stuff, but it’s just something that I’ve been thinking about, right? You’d be a bad investor if you didn’t. If you looked and said, “Hey, a handful of your stocks from a year ago to 2 years ago have done really well over the past few years, better than the stocks you’ve owned,” what’s the break in the process? Was this good process? Was this some issue with you? It’s just something I have been thinking about.

There is probably also an element of bull markets, right? Since the early-April tariff delays, stocks are up a lot. Maybe these stocks I had held had excess risk. A lot of the stocks I’m comparing them with—I was and am still big in net-cash biotech, right? So, if I’m doing Nevro, which has a lot of cash but morphs into kind of an AI play, and we live in a world where the AI play works really well, there’s a world where the AI play didn’t work out well. Maybe the net-cash stuff, which has done pretty well, does pretty well in all worlds, or most worlds, and maybe the AI play only plays well in this one.

It’s just something I’ve been debating, and I’m not breaking new ground by saying this, right? I think all investors are evolving, but it’s something that’s been on my mind this month, and I thought I’d share it with you. I think that goes back well to the earlier things I was talking about: the arrogance of being an investor and being an active investor.

Let me go quickly to the London Stock Exchange. If you listen to the podcast regularly, anytime somebody comes on and pitches a London stock, I joke that it’s an emerging market. I just wanted to quickly mention it because literally this week, I believe, there was a company, Mitie—it’s MTO over in London—that got taken over for a big premium.

I saw a news article that said—the headline quote is—“We’re going to run out.” What they’re saying is, “We’re going to run out of London-listed firms.” Mitie, and I’m looking at the article as I speak, is the 11th £1 billion-plus takeover from the FTSE 250 so far this year.

It’s interesting, right? London is so devastated as a stock market and all this sort of stuff that you’re having private-equity firms come in and pay big premiums. EasyJet, which is a low-budget airline, got taken out by Apollo, I believe, for—gosh, I can’t even remember. If I were a professional podcaster, I would have looked up the premium, but they got taken out for a big premium. Mitie gets taken out for a big premium. All these things are getting taken out for big premiums, which suggests private-market value is much higher than public-market value, right?

There are 2 interesting things there. First, we’re going to run out of firms—we’re going to run out of public companies. It’s interesting because all of these are trading at such low valuations given such big premiums, and you would think, from a supply-and-demand point of view, that if you’re about to run out of companies, one of the reasons people talk about Australia trading at a structural premium is that they have a lot of pension funds that are forced to put money into the stock market.

There are only so many companies, and the pension funds are always having cash inflows, so they structurally boost the multiples because you’ve got this structural buyer. It’s kind of demand exceeds supply. Heck, the S&P 500—one of the reasons I know a lot of people think the S&P 500 multiple expands over time is because people save, wealth grows, people save, they put money into the S&P 500, and the index just buys. As you get bigger, the index is forced to buy more of you.

From a supply-and-demand perspective, it is kind of interesting. You’ve got this beaten-down stock market where companies are getting taken out for huge premiums, and the remaining companies don’t seem to be getting much of a boost. At some point, it seems like demand should be overwhelming supply because supply is shrinking so quickly.

The other side of it is just the huge premiums. Private value is much higher than public value. It’s really interesting, right? But I said the FTSE 250: 11 takeovers, 11 takeouts. That’s still only 4% to 5% of the 250, right? 11 divided by 250.

If you are an active manager and let’s say you’re running a concentrated portfolio—you’re running 10 stocks—it’s not only possible, it’s probable that you weren’t long any of these big-premium takeout stocks. The reason I mention that is because, again, bringing it back to me, my experience with London is that I’ve got 3 to 4 London stocks in my portfolio. I think it was 4, and I sold 1 of them out of frustration.

My stocks go nowhere. It’s just interesting: if you’re an active manager in London, your portfolio is doing terribly unless you were long one of these companies that got taken out. It’s tough because you can go and say, “Hey, private-market values are so much higher. Look at this. Look at the takeouts. Look at the work I’m doing. Look at the comps, whatever you want.”

But when you’ve got a market that’s broken like this, and the only way to get premiums is to get these takeouts, it sounds great in theory. In practice, it’s like, “Hey, I’m underperforming constantly despite knowing that private-market value is so much higher.” What’s the solution? I have no clue what the solution is, but I think it’s really interesting to think about.

You know, there was a line somebody said to me once: “Every investor wants to be invested in an inefficient market until they’re actually invested in an inefficient market.” Then they come and say, “Hey, look, I found this great value.” They buy it, and then a year later they’re like, “Hey, it’s even better value now, but it hasn’t gone up. The stock hasn’t done anything.” Then probably the old-timers say, “Welcome to the party, pal,” or something like that.

But it’s just interesting. I’m not saying every stock on the London Stock Exchange is listed, but go look—go run through them. You’ll be able to find some pretty interesting values pretty quickly, I would suspect. It’s interesting when you say, “Hey, the only thing that can make these things work is a takeout.” And guess what? In a lot of these firms, insider ownership is low. They’re loath to sell. If they do, they’re all going to lose their pensions, their salaries, and their board fees.

For me, what I’ve started saying is: You look at it every day and say, “This thing is so cheap.” But then you start wondering, “Hey, is management ever going to do the right thing?” Management will say, “We’re doing the right thing. We’re growing our intrinsic value every day.” But from a shareholder perspective, you’re saying, “Hey, the stock is going nowhere. The only way we’ll ever get value is a private equity sale.”

It starts to weigh on you. You say, “Hey, if they don’t sell, I’ll never go anywhere. So, do I need to—” It’s a great case for activism, obviously, but what can I do? Should I just go elsewhere? Do I want to take my chances on the coin flip that I have one of the 5% of companies that are going to get taken over? Do I want to risk my value investing principles? Do I want to evolve, as I talked about earlier? I don’t know.

Anyway, we’re at about 30 minutes. I’m probably going to wrap it up here. Look, these have been my random ramblings for the month of July. It is July 22nd as I randomly ramble. I've got some good podcasts coming up. I hope you guys are having a great summer. I’m looking forward to talking to you. I don’t know what I’m going to ramble on about, but I’ll ramble again for 30 minutes in August.

A quick disclaimer: Nothing on this podcast should be considered investment advice. Guests or the host may have positions in any of the stocks mentioned during this podcast. Please do your own work and consult a financial adviser.